Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
17Cicada logo — low-carbon synthesis; high-value products

17Cicada

low-carbon synthesis; high-value products

Founded 2021 United Kingdom Cambridge, United Kingdom 11 employees Grant Total: $413.80K Biotechnology, Pharmaceutical +1

General Information

Company Name 17Cicada
Founded Year 2021
Location United Kingdom Cambridge, United Kingdom +1
Employees 11
Industries Biotechnology, Pharmaceutical, Waste Solution
Funding Stage Grant
Social

Get notified when 17Cicada moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About 17Cicada

17Cicada is a UK-based startup founded in 2021 with a mission to revolutionize the production of chemical and microbial products. The company's expertise lies in low-carbon synthesis, microbial synthesis using Cyanobacteria and Streptomyces, resource recirculation, and genetic manipulation of microbes for industrial and medical purposes. The company advocates for minimal cash-burn and focuses on developing materials that consumers have already shown an interest in. Notable unique selling points include low-carbon synthesis, microbial processes that utilize carbon dioxide or waste feedstocks, non-pathogenic bacteria platforms, and high-throughput synthesis of novel molecules. Their recent £413.80K grant investment received on 31 May 2023 from the Farming Innovation Programme emphasizes the recognition and support for their innovative approach in the Biotechnology and Pharmaceutical industries. With experienced co-founders at the helm, 17Cicada is poised for significant growth and impact in the market.

Taxonomy: Low-carbon synthesis, Microbial synthesis, Cyanobacteria, Strptomyces, Resource recirculation, Circular economy, Genetic manipulation of microbes, Industrial products, Medical products, Lean startup, Minimal cash-burn, Consumer demand-driven, Bacterial platform, CO2 conversion, High-value products

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
31 May 2023
Pre Seed Round •••••• 1
Investor
01 Feb 2023

17Cicada Alternatives & Competitors

17Cicada vs
Bio Synthesis
Bio Synthesis United States

Life Sciences Company

43 employees
Biotechnology, Health Care
17Cicada vs
ChemContract Research, Inc.
ChemContract Research, Inc. United States

Providing simple solutions to your complex Chemistry needs

2 employees
17Cicada vs
Beijing SBS Genetech Co., Ltd.
Beijing SBS Genetech Co., Ltd. China

From China, for the World. For Superior Biology Services since 2000

4 employees
Biotechnology

FAQ About 17Cicada

low-carbon synthesis; high-value products
17Cicada was founded in 2021.
17Cicada is headquartered in Cambridge, United Kingdom.
17Cicada operates in the following industries: Biotechnology, Pharmaceutical, Waste Solution.
17Cicada has approximately 11 employees.
17Cicada has completed 2 funding rounds, raising a total of $413.80K. The latest funding stage is Grant.
Top alternatives and competitors to 17Cicada include Bio Synthesis , ChemContract Research, Inc., Beijing SBS Genetech Co., Ltd., Jupiter Ionics, NANOINGREEN. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
17Cicada and Bio Synthesis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors 17Cicada and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes